PRL and diffuse large B-cell lymphoma: To determine whether the PRL-LFPRLR axis elevates the risk of establishment of overt B-cell malignancies from pre-malignant B cells, we compared B-cell pathology in DLBCL-prone CD79b-TCL1-tg mice28, treated with either control SMO or LFPRLR SMO.